TG Therapeutics, Inc.
TGTX
$37.25
-$0.10-0.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 23.38M | -14.36M | 95.69M | 41.20M | 12.67M |
| Total Depreciation and Amortization | 68.00K | 97.00K | 159.00K | 172.00K | 211.00K |
| Total Amortization of Deferred Charges | 2.21M | 2.54M | 2.77M | 2.77M | 2.59M |
| Total Other Non-Cash Items | 43.12M | 40.25M | 34.10M | 38.55M | 37.77M |
| Change in Net Operating Assets | -109.30M | -56.61M | -64.89M | -62.40M | -84.66M |
| Cash from Operations | -40.52M | -28.09M | 67.82M | 20.28M | -31.41M |
| Capital Expenditure | -45.00K | -24.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -991.00K | -61.56M | -82.47M | -53.74M | -50.65M |
| Cash from Investing | -1.04M | -61.58M | -82.47M | -53.74M | -50.65M |
| Total Debt Issued | 244.82M | 244.82M | 0.00 | 0.00 | 25.00M |
| Total Debt Repaid | -107.55M | -107.55M | -- | -- | -- |
| Issuance of Common Stock | 914.00K | 344.00K | 566.00K | 47.48M | 47.83M |
| Repurchase of Common Stock | -8.76M | -2.15M | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -889.00K | -858.00K | 0.00 | 0.00 | -125.00K |
| Cash from Financing | 128.53M | 134.60M | 565.00K | 47.48M | 72.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 86.97M | 44.93M | -14.09M | 14.02M | -9.36M |
